HSDB 419
Brand names,
HSDB 419
Analogs
HSDB 419
Brand Names Mixture
HSDB 419
Chemical_Formula
As2O3
HSDB 419
RX_link
http://www.rxlist.com/cgi/generic2/arsenic.htm
HSDB 419
fda sheet
HSDB 419
msds (material safety sheet)
HSDB 419
Synthesis Reference
No information avaliable
HSDB 419
Molecular Weight
197.841 g/mol
HSDB 419
Melting Point
No information avaliable
HSDB 419
H2O Solubility
No information avaliable
HSDB 419
State
Solid
HSDB 419
LogP
No information avaliable
HSDB 419
Dosage Forms
Tablet
HSDB 419
Indication
For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression
HSDB 419
Pharmacology
Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.
HSDB 419
Absorption
No information avaliable
HSDB 419
side effects and Toxicity
Symptoms of overdose include convulsions, muscle weakness and confusion.
HSDB 419
Patient Information
No information avaliable
HSDB 419
Organisms Affected
Humans and other mammals